| 11. |
Fluoxetine improves symptoms in minor depressive disorder |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 12. |
Solifenacin succinate improves OAB symptoms, including nocturia |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 14-14
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 13. |
Prolonged survival with liposomal doxorubicin in ovarian cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 15-15
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 14. |
Sirolimus-eluting stents SMART option in small coronary arteries |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 15. |
Aprepitant an advance on standard antiemetic regimen for MEC |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 17-18
RM Poole,
Preview
|
|
摘要:
Aprepitant [Emend], given in combination with conventional antiemetic therapy, is more effective than the established regimen alone in preventing chemotherapy-induced nausea and vomiting, according to a study presented at the European Society of Medical Oncology (ESMO) meeting [Vienna, Austria; October−November 2004]. In a large study involving patients receiving moderately emetogenic chemotherapy (MEC) for breast cancer, the addition of aprepitant enhanced the efficacy of a regimen comprising ondansetron plus dexamethasone. Furthermore, the benefits observed with aprepitant were maintained over multiple treatment cycles."These are exciting results... Reducing chemotherapy induced nausea and vomiting, and the associated distress and disruption to daily activities, remains an important target for therapeutic intervention,"commented Dr Carsten Bokemeyer from the University of Tübingen, Germany.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 16. |
Sirolimus-based therapy promising in liver transplantation |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 17. |
Paroxetine metabolism is affected by cytochrome P450 (CYP) 2D6 polymorphism, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 18. |
Inhaled triamcinolone associated with BMD loss |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 20-20
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 19. |
Adverse effects related to antiepileptic medications can greatly impair patients' quality of life (QOL) and their ability to perform daily activities, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 21-21
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 20. |
Topical 1% clindamycin [Evoclin] has been launched commercially in the US, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1468,
2004,
Page 22-22
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
